Home › Overweight › Arizona › Phoenix
Pag-aaral pangklinika para sa Overweight sa Phoenix, AZ
Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Phoenix. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Nagre-recruitPhase 3
- Absolute Clinical Research, Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Nagre-recruitPhase 4
- Medical Dermatology Specialists, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Nagre-recruitPhase 3
- RIO Clinical Trials - Phoenix, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Nagre-recruitPhase 3
- Elite Clinical Studies, LLC, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Nagre-recruitPhase 2
- Helios Clinical Research - Phoenix, Phoenix
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
Nagre-recruitPhase 1
- Arizona Research Center, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Nagre-recruitPhase 3
- Research Site, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Nagre-recruitObservasyonal na pag-aaral
- Exponent Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 3
- AURORA-1 Clinical Site, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Nagre-recruitPhase 3
- ACCOMPLISH-1 Research Site, Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Nagre-recruitPhase 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
Pag-aaral para sa Overweight sa ibang lungsod
- San Antonio, TX34 pag-aaral
- Houston, TX33 pag-aaral
- Chicago, IL29 pag-aaral
- Orlando, FL27 pag-aaral
- Dallas, TX23 pag-aaral
- Miami, FL23 pag-aaral
- Washington, DC20 pag-aaral
- Atlanta, GA20 pag-aaral
- Austin, TX19 pag-aaral
- Las Vegas, NV19 pag-aaral
- Jacksonville, FL19 pag-aaral
- New York City, NY19 pag-aaral
Iba pang pag-aaral sa Phoenix
- Kanser sa Suso25 pag-aaral
- Colorectal Cancer24 pag-aaral
- Non-Small Cell Lung Cancer21 pag-aaral
- Metastatic Cancer19 pag-aaral
- Obesity19 pag-aaral
- Kanser sa Pancreas18 pag-aaral
- Kanser (lahat ng uri)17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo16 pag-aaral
- Kanser sa Prostate16 pag-aaral
- Multiple Myeloma16 pag-aaral
- Pagkabigo ng Puso16 pag-aaral
- Sakit ni Alzheimer15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.